IBRN (iShares Neuroscience and Healthcare ETF) Stock Analysis - Hedge Fund Holdings

iShares Neuroscience and Healthcare ETF (IBRN) is a publicly traded the market company. As of May 21, 2026, IBRN trades at $28.16 with a market cap of $0 and a P/E ratio of 0.00. IBRN moved +0.89% today. Year to date, IBRN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns IBRN stock?

Rallies tracks hedge fund and 13F ownership for IBRN, including fund holders, share counts, and position changes when data is available.

IBRN Key Metrics

Key financial metrics for IBRN
MetricValue
Price$28.16
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

IBRN Analyst Consensus

IBRN analyst coverage data. Average price target: $0.00.

Common questions about IBRN

Who owns IBRN stock?
Rallies tracks hedge fund and 13F ownership for IBRN, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for IBRN?
Yes. Rallies tracks hedge fund and 13F ownership data for IBRN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IBRN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBRN. It does not provide personalized investment advice.
IBRN

IBRN